1073 related articles for article (PubMed ID: 28718050)
21. Two-phase delivery using a horse oil and adenosine-loaded dissolving microneedle patch for skin barrier restoration, moisturization, and wrinkle improvement.
Yang H; Kim S; Jang M; Kim H; Lee S; Kim Y; Eom YA; Kang G; Chiang L; Baek JH; Ryu JH; Lee YE; Koh J; Jung H
J Cosmet Dermatol; 2019 Jun; 18(3):936-943. PubMed ID: 30160014
[TBL] [Abstract][Full Text] [Related]
22. Improved immunogenicity of individual influenza vaccine components delivered with a novel dissolving microneedle patch stable at room temperature.
Vassilieva EV; Kalluri H; McAllister D; Taherbhai MT; Esser ES; Pewin WP; Pulit-Penaloza JA; Prausnitz MR; Compans RW; Skountzou I
Drug Deliv Transl Res; 2015 Aug; 5(4):360-71. PubMed ID: 25895053
[TBL] [Abstract][Full Text] [Related]
23. Dissolving polymer microneedle patches for rapid and efficient transdermal delivery of insulin to diabetic rats.
Ling MH; Chen MC
Acta Biomater; 2013 Nov; 9(11):8952-61. PubMed ID: 23816646
[TBL] [Abstract][Full Text] [Related]
24. Vaccination of fish against Aeromonas hydrophila infections using the novel approach of transcutaneous immunization with dissolving microneedle patches in aquaculture.
Yun S; Lee SJ; Giri SS; Kim HJ; Kim SG; Kim SW; Han SJ; Kwon J; Oh WT; Chang Park S
Fish Shellfish Immunol; 2020 Feb; 97():34-40. PubMed ID: 31841693
[TBL] [Abstract][Full Text] [Related]
25. Dissolving polymer microneedle patches for influenza vaccination.
Sullivan SP; Koutsonanos DG; Del Pilar Martin M; Lee JW; Zarnitsyn V; Choi SO; Murthy N; Compans RW; Skountzou I; Prausnitz MR
Nat Med; 2010 Aug; 16(8):915-20. PubMed ID: 20639891
[TBL] [Abstract][Full Text] [Related]
26. Finite element analysis and optimization of microneedle arrays for transdermal vaccine delivery: comparison of coated and dissolving microneedles.
Yolai N; Suttirat P; Leelawattanachai J; Boonyasiriwat C; Modchang C
Comput Methods Biomech Biomed Engin; 2023 Sep; 26(12):1379-1387. PubMed ID: 36048187
[TBL] [Abstract][Full Text] [Related]
27. Laser-engineered dissolving microneedle arrays for protein delivery: potential for enhanced intradermal vaccination.
McCrudden MT; Torrisi BM; Al-Zahrani S; McCrudden CM; Zaric M; Scott CJ; Kissenpfennig A; McCarthy HO; Donnelly RF
J Pharm Pharmacol; 2015 Mar; 67(3):409-25. PubMed ID: 24673568
[TBL] [Abstract][Full Text] [Related]
28. [Microneedle-based percutaneous immunity: a review].
Li Y; Wang J; Jin Z; Wan W; Bai X; Hu C; Li Y; Xin W; Kang L; Yang H; Wang J; Gao S
Sheng Wu Gong Cheng Xue Bao; 2022 Sep; 38(9):3301-3315. PubMed ID: 36151801
[TBL] [Abstract][Full Text] [Related]
29. Cutaneous vaccination: antigen delivery into or onto the skin.
Weniger BG; Glenn GM
Vaccine; 2013 Jul; 31(34):3389-91. PubMed ID: 23684830
[No Abstract] [Full Text] [Related]
30. Toward Biofunctional Microneedles for Stimulus Responsive Drug Delivery.
Cahill EM; O'Cearbhaill ED
Bioconjug Chem; 2015 Jul; 26(7):1289-96. PubMed ID: 26020359
[TBL] [Abstract][Full Text] [Related]
31. Intradermal and transdermal drug delivery using microneedles - Fabrication, performance evaluation and application to lymphatic delivery.
Sabri AH; Kim Y; Marlow M; Scurr DJ; Segal J; Banga AK; Kagan L; Lee JB
Adv Drug Deliv Rev; 2020 Jan; 153():195-215. PubMed ID: 31634516
[TBL] [Abstract][Full Text] [Related]
32. Bletilla striata polysaccharide microneedle for effective transdermal administration of model protein antigen.
Zhou P; Zhao S; Huang C; Qu Y; Zhang C
Int J Biol Macromol; 2022 Apr; 205():511-519. PubMed ID: 35217076
[TBL] [Abstract][Full Text] [Related]
33. Microneedle Systems for Vaccine Delivery: the story so far.
Hossain MK; Ahmed T; Bhusal P; Subedi RK; Salahshoori I; Soltani M; Hassanzadeganroudsari M
Expert Rev Vaccines; 2020 Dec; 19(12):1153-1166. PubMed ID: 33427523
[TBL] [Abstract][Full Text] [Related]
34. Dissolving microneedles: Applications and growing therapeutic potential.
Sartawi Z; Blackshields C; Faisal W
J Control Release; 2022 Aug; 348():186-205. PubMed ID: 35662577
[TBL] [Abstract][Full Text] [Related]
35. Production of dissolvable microneedles using an atomised spray process: effect of microneedle composition on skin penetration.
McGrath MG; Vucen S; Vrdoljak A; Kelly A; O'Mahony C; Crean AM; Moore A
Eur J Pharm Biopharm; 2014 Feb; 86(2):200-11. PubMed ID: 23727511
[TBL] [Abstract][Full Text] [Related]
36. Microneedle arrays for vaccine delivery: the possibilities, challenges and use of nanoparticles as a combinatorial approach for enhanced vaccine immunogenicity.
Rodgers AM; Cordeiro AS; Kissenpfennig A; Donnelly RF
Expert Opin Drug Deliv; 2018 Sep; 15(9):851-867. PubMed ID: 30051726
[TBL] [Abstract][Full Text] [Related]
37. Advances in microneedle-based transdermal delivery for drugs and peptides.
Aich K; Singh T; Dang S
Drug Deliv Transl Res; 2022 Jul; 12(7):1556-1568. PubMed ID: 34564827
[TBL] [Abstract][Full Text] [Related]
38. Microneedles-Based Transdermal Drug Delivery Systems: A Review.
Hao Y; Li W; Zhou X; Yang F; Qian Z
J Biomed Nanotechnol; 2017 Dec; 13(12):1581-1597. PubMed ID: 29490749
[TBL] [Abstract][Full Text] [Related]
39. Current advances in the fabrication of microneedles for transdermal delivery.
Indermun S; Luttge R; Choonara YE; Kumar P; du Toit LC; Modi G; Pillay V
J Control Release; 2014 Jul; 185():130-8. PubMed ID: 24806483
[TBL] [Abstract][Full Text] [Related]
40. Measles vaccination using a microneedle patch.
Edens C; Collins ML; Ayers J; Rota PA; Prausnitz MR
Vaccine; 2013 Jul; 31(34):3403-9. PubMed ID: 23044406
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
